Plasmodium falciparum Carriage in central and northern Mali amid Seasonal Malaria Chemoprevention implementation

This study characterizes *Plasmodium falciparum* carriage dynamics in central and northern Mali, revealing that while Seasonal Malaria Chemoprevention reduces infection in young children, asymptomatic carriers aged 10–24 in central Mali and a generalized high-burden reservoir in northern Mali sustain transmission, suggesting a need for targeted interventions beyond current SMC coverage.

The Gist

The Big Picture: The Malaria "Ghost" in Mali

Imagine malaria as a ghost that haunts a village. Usually, the ghost is loud and scary (causing fever and sickness) during the rainy season, but it seems to disappear when the sun comes out and the ground dries up.

For years, health workers in Mali have been using a powerful shield called Seasonal Malaria Chemoprevention (SMC). Think of SMC as a monthly "force field" given to young children (under 5 years old) during the rainy season. It works incredibly well at keeping the ghost away from these little ones.

But here is the mystery: Even though the children are protected, the ghost (the malaria parasite) never fully leaves the village. It just hides. This study went into two different villages in Mali to find out: Where is the ghost hiding, and who is carrying it?

---

The Two Villages: A Tale of Two Ecosystems

The researchers studied two very different neighborhoods to see how the "ghost" behaves in different environments.

1. Kati (Central Mali): The Rain-Driven Village

• The Setting: This village follows the classic Sahelian pattern. The malaria season is strictly tied to the rain. When it rains, mosquitoes breed, and malaria spikes. When it's dry, the mosquitoes vanish.
• The Shield: They have the monthly medicine (SMC) for kids under 5.
• The Discovery:
  • The little kids (under 5) were mostly safe, thanks to the medicine.
  • The Twist: The "ghost" wasn't gone; it had moved house. It was hiding in older children and teenagers (ages 10–24).
  • These older kids didn't get sick enough to go to the doctor, so they didn't get treated. They were "silent carriers." They carried the parasite in their blood like a backpack, passing it back to mosquitoes, which then bit the little kids again.
  • Analogy: Imagine a school where the teachers (SMC) protect the kindergarteners. But the high schoolers are sneaking contraband into the school. The teachers aren't looking at the high schoolers, so the contraband keeps getting in.

2. Dire (Northern Mali): The Flood-Driven Village

• The Setting: This village is near the Niger River. Here, malaria isn't just about rain; it's about flooding. The river swells, creating massive breeding grounds for mosquitoes that last for months.
• The Shield: In this specific year, the monthly medicine (SMC) was cancelled due to shortages.
• The Discovery:
  • Without the shield, the "ghost" was everywhere. High infection rates were found in everyone, from toddlers to adults.
  • The river flooding created a "super-highway" for malaria, keeping transmission high even when it wasn't raining heavily.
  • Analogy: If Kati was a leaky roof that only drips when it storms, Dire was a dam that broke. The water (malaria) flooded the whole house, and without a bucket (SMC) to catch it, everyone got wet.

---

The "Invisible" Carriers

One of the most important findings is about how the parasite hides.

• The Low-Profile Ghost: In many cases, the people carrying the parasite had very low levels of it in their blood. It was so low that standard rapid tests (the kind used at clinics) couldn't see it.
• The Analogy: Imagine a smoke detector. If there is a thick cloud of smoke (high fever), the alarm goes off, and firefighters (doctors) come to put it out. But if there is just a tiny wisp of smoke (low parasite count), the alarm stays silent. The fire is still smoldering, but no one knows it's there.
• The Result: These "silent carriers" (mostly teenagers and young adults) keep the fire alive. They don't feel sick, so they don't get treated, but they keep passing the infection to mosquitoes.

The "Party" Analogy (Multiplicity of Infection)

The researchers also looked at how many different types of malaria parasites were in one person's blood. They call this the "Multiplicity of Infection."

• The Metaphor: Imagine a party.
  • Monoclonal: One person shows up with one guest. (Simple infection).
  • Polyclonal: One person shows up with a whole group of different friends. (Complex infection).
• The Finding: In both villages, many people had "polyclonal" infections. They were hosting a whole party of different malaria strains. This means the mosquitoes were biting them, picking up different strains, and spreading a very diverse mix of malaria to the rest of the village. This makes it harder to eliminate the disease because the parasite is constantly mixing and matching.

What Does This Mean for the Future?

The study concludes that our current strategy has a blind spot.

1. The Shield is Good, but Narrow: The monthly medicine (SMC) is a hero for children under 5. It saves lives.
2. The Blind Spot: However, once kids grow up and "age out" of the program (turning 5), they lose their shield. They become the new reservoir for the disease.
3. The Solution: To truly stop malaria in these areas, we can't just protect the toddlers. We need to expand the shield.
   • Maybe give the medicine to older kids (up to age 10 or even 15).
   • Maybe treat the "silent carriers" (the teenagers with low-level infections) even if they don't feel sick.
   • We need to look at the whole village, not just the nursery.

The Bottom Line

Malaria in Mali is like a game of musical chairs. We have successfully protected the smallest children, but the music hasn't stopped. The "chairs" (the parasite reservoir) have just shifted to the older children and young adults. If we want to win the game and eliminate malaria, we need to expand our protection to include the whole family, not just the little ones.

Technical Summary

1. Problem Statement

Despite the widespread implementation of Seasonal Malaria Chemoprevention (SMC) in Sahelian countries like Mali, which has significantly reduced clinical malaria incidence in children under five, transmission persists at substantial levels.

• The Gap: Current interventions focus on clinical cases and vector control but fail to address the asymptomatic parasite reservoir. These chronic, subclinical infections maintain transmission during dry seasons and fuel resurgence when conditions become favorable.
• The Knowledge Gap: There is limited understanding of how SMC alters the age-distribution of the parasite reservoir, particularly in regions with varying transmission dynamics (classic rainfall-driven vs. flood-driven) and in populations beyond the standard SMC eligibility age (currently <5 years in Mali).

2. Methodology

The study employed a prospective cohort design across two distinct epidemiological settings in Mali over one year (2021–2022):

• Study Sites:
  • Kati (Central Mali): A "classic" Sahelian setting with rainfall-driven transmission. SMC (SP-AQ) was implemented for children aged 3–59 months.
  • Dire (Northern Mali): A Niger River inner delta setting with bimodal transmission driven by both rainfall and river flooding. SMC was not implemented in 2021 due to drug shortages, serving as a natural control/comparison.
• Participants: 670 individuals from 98 households in four villages (Safo, Torodo in Kati; Bourem Sidi Amar, Koigour in Dire).
• Data Collection:
  • Four Survey Visits (T0–T3): Conducted across dry and wet seasons.
  • Diagnostic Tools: Rapid Diagnostic Tests (RDT), microscopy, and highly sensitive quantitative PCR (qPCR) targeting varATS and CytB genes.
  • Genotyping: PCR-positive samples were genotyped using a 101-SNP "molecular barcode" to estimate the effective Multiplicity of Infection (eMOI) using the Bayesian MOIRE package.
  • Clinical Surveillance: Passive case detection at local health facilities.
• Statistical Analysis: Generalized Additive Multilevel Models (GAMM) were used to identify factors associated with carriage, accounting for clustering and repeated measures.

3. Key Contributions

• Dual-Setting Comparison: Provides rare comparative data between a classic Sahelian setting with high SMC coverage and a flood-driven setting without SMC.
• Reservoir Characterization: Moves beyond clinical incidence to map the asymptomatic reservoir using molecular diagnostics, revealing that the majority of infections are subpatent (RDT-negative).
• Genetic Complexity: Utilizes high-resolution genotyping to assess parasite diversity (eMOI), linking genetic complexity to transmission intensity and age groups.
• SMC Impact Assessment: Quantifies how SMC shifts the burden of infection from young children to older age groups (5–24 years).

4. Key Results

A. Epidemiological Dynamics

• Kati (SMC Implemented):
  • Seasonality: Driven by rainfall. Prevalence rose from 21.5% (dry season) to 33.5% (post-rainy season).
  • Age Distribution: Children <5 years had the lowest prevalence (protected by SMC). The **10–24 age group** exhibited the highest prevalence (>40% in December) and the highest parasite densities.
  • Clinical Incidence: Highest in children aged 5–9 years (immediately above SMC eligibility).
• Dire (No SMC):
  • Seasonality: Driven by Niger River flooding. Prevalence was high at baseline (60%) and remained high (50–70%) across all age groups in December.
  • Age Distribution: No significant protection for <5s; high prevalence was homogenous across all ages.
  • Clinical Incidence: Peaked during the flood season (Dec–Mar), with high incidence in ages 5–24.

B. Parasite Density and Detection

• Subpatent Infections: Over 50% of infections had parasite densities <100 parasites/µL.
• RDT Sensitivity: Extremely low in the cohort (6–28% in Kati; 21–32% in Dire), indicating that RDTs miss the vast majority of the asymptomatic reservoir, particularly in adults and older children.

C. Genetic Complexity (eMOI)

• Polyclonality: Predominant in both sites (Kati: 71.7%; Dire: 66.8%).
• Age Trends:
  • Kati: Highest eMOI in the 10–19 age group.
  • Dire: Highest eMOI in the 20–24 age group.
  • Implication: Even children who received SMC as infants (now aged 5–10) carry complex, polyclonal infections, suggesting they act as significant reservoirs.

D. Risk Factors

• Prior Infection: In Kati, qPCR positivity at T1 was a strong predictor of infection at T2 (OR = 5.22).
• SMC Eligibility: In Kati, non-eligible participants had significantly higher odds of infection compared to SMC-eligible children (OR = 16.29).
• Behavior: Travel (>1 week) in Dire was associated with lower odds of infection, possibly due to migration away from high-transmission zones.

5. Significance and Implications

• Shifting Reservoir: SMC successfully protects children <5, but the parasite reservoir has shifted to older children and young adults (5–24 years). This group now carries the highest burden of asymptomatic, high-density, and genetically complex infections.
• Limitations of Current Strategy: Relying solely on SMC for <5s and RDT-based treatment is insufficient for elimination because it leaves a large, untreated, asymptomatic reservoir that sustains transmission.
• Strategic Recommendations:
  • Expand SMC: Consider extending SMC eligibility beyond 5 years (e.g., up to 10 or 15 years) or implementing school-based delivery.
  • Target Asymptomatic Carriers: Interventions must target the 5–24 age demographic to break the transmission cycle.
  • Molecular Surveillance: Genetic metrics like eMOI are essential for monitoring transmission intensity and the impact of interventions, as they detect shifts in parasite population structure that clinical data miss.
• Ecological Context: The study highlights that transmission dynamics are highly context-specific (rainfall vs. flooding), requiring tailored interventions for different regions within the same country.

Conclusion: The study demonstrates that while SMC reduces clinical disease in young children, it inadvertently concentrates the asymptomatic reservoir in older age groups. To achieve malaria elimination in seasonal settings, strategies must evolve to target these older, asymptomatic carriers who sustain transmission.